Envista Holdings (NVST) Free Cash Flow (2018 - 2026)
Envista Holdings' (NVST) quarterly Free Cash Flow came in at -$15.8 million in Q2 2026, down 182.14% year-on-year from $19.2 million in Q2 2025, and down 117.23% quarter-over-quarter from $91.7 million in Q4 2025.
Envista Holdings (NVST) Free Cash Flow (2018 - 2026) Analysis & Trends
Envista Holdings' Free Cash Flow history runs 9 years deep, the most recent figure standing at -$15.8 million for Q2 2026.
- On a quarterly basis, Free Cash Flow fell 182.14% year-over-year to -$15.8 million in Q2 2026; TTM through Apr 2026 was $220.2 million, a 17.77% decrease from a year earlier, with the FY2025 full-year figure at $230.4 million, down 23.89% from the prior year.
- Free Cash Flow slipped to -$15.8 million in Q2 2026 per NVST's latest filing, from $91.7 million in the prior quarter.
- Across five years, Free Cash Flow topped out at $123.8 million in Q4 2024 and bottomed at -$16.3 million in Q2 2022.
- The 5-year median for Free Cash Flow is $63.3 million (2024), against an average of $49.5 million.
- Across the five-year window, Free Cash Flow tumbled 296.39% in 2022 and jumped 503.96% in 2023, its largest moves.
- Year by year, Free Cash Flow stood at $93.4 million in 2022, then increased by 0.43% to $93.8 million in 2023, then surged by 31.98% to $123.8 million in 2024, then dropped by 25.93% to $91.7 million in 2025, then tumbled by 117.23% to -$15.8 million in 2026.
- Per Business Quant, the three latest NVST Free Cash Flow figures stand at -$15.8 million (Q2 2026), $91.7 million (Q4 2025), and $67.9 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 557.00 Mn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 1.10 Bn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | 546.00 Mn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 316.00 Mn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 520.48 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 80.80 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 96.40 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | -273.00 Mn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 120.26 Mn |
| 10 | Envista Holdings | 4.29 Bn | 3.20 Bn | 390.10 Mn | -15.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | -15.80 Mn |
| Apr 3, 2026 | -15.80 Mn |
| Dec 31, 2025 | 91.70 Mn |
| Dec 31, 2025 | 91.70 Mn |
| Sep 26, 2025 | 67.90 Mn |
| Sep 26, 2025 | 67.90 Mn |
| Jun 27, 2025 | 76.40 Mn |
| Jun 27, 2025 | 76.40 Mn |
| Mar 28, 2025 | -5.60 Mn |
| Mar 28, 2025 | -5.60 Mn |
| Dec 31, 2024 | 123.80 Mn |
| Dec 31, 2024 | 123.80 Mn |
| Sep 27, 2024 | 63.30 Mn |
| Sep 27, 2024 | 63.30 Mn |
| Jun 28, 2024 | 86.30 Mn |
| Jun 28, 2024 | 86.30 Mn |
| Mar 29, 2024 | 29.30 Mn |
| Mar 29, 2024 | 29.30 Mn |
| Dec 31, 2023 | 93.80 Mn |
| Dec 31, 2023 | 93.80 Mn |